Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00412022 |
|---|---|
| Brief Title: | HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer. (HOBOE) |
| First Submitted : | December 14, 2006 |
| First Submitted that Met QC Criteria : | December 14, 2006 |
| First Posted : | December 15, 2006 (Estimate) |
| Last Update Submitted that Met QC Criteria : | March 23, 2023 |
| Last Update Posted : | March 24, 2023 |